[1] Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med, 2010; 362, 886-95. doi:  10.1056/NEJMoa0907272
[2] Bradley SM, Spertus JA, Kennedy KF, et al. Patient selection for diagnostic coronary angiography and hospital-level percutaneous coronary intervention appropriateness:insights from the National Cardiovascular Data Registry. JAMA Intern Med, 2014; 174, 1630-9. doi:  10.1001/jamainternmed.2014.3904
[3] Sorajja P, Gersh BJ, Cox DA, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J, 2007; 28, 1709-16. doi:  10.1093/eurheartj/ehm184
[4] Park DW, Clare RM, Schulte PJ, et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA, 2014; 312, 2019-27. doi:  10.1001/jama.2014.15095
[5] Min JK, Dunning A, Lin FY, et al. Age-and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes:An International Multicenter Registry) of 23, 854 patients without known coronary artery disease. J Am Coll Cardiol, 2011; 58, 849-60. doi:  10.1016/j.jacc.2011.02.074
[6] Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009; 360, 961-72. doi:  10.1056/NEJMoa0804626
[7] Grodin JL, Simon J, Hachamovitch R, et al. Prognostic Role of Serum Chloride Levels in Acute Decompensated Heart Failure. J Am Coll Cardiol, 2015; 66, 659-66. doi:  10.1016/j.jacc.2015.06.007
[8] Goldberg A, Hammerman H, Petcherski S, et al. Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction. Am J Med, 2004; 117, 242-8. doi:  10.1016/j.amjmed.2004.03.022
[9] Goldberg A, Hammerman H, Petcherski S, et al. Hyponatremia and long-term mortality in survivors of acute ST-elevation myocardial infarction. Arch Intern Med, 2006; 166, 781-6. doi:  10.1001/archinte.166.7.781
[10] Singla I, Zahid M, Good CB, et al. Effect of hyponatremia (< 135 mEq/L) on outcome in patients with non-ST-elevation acute coronary syndrome. Am J Cardiol, 2007; 100, 406-8. doi:  10.1016/j.amjcard.2007.03.039
[11] Burkhardt K, Kirchberger I, Heier M, et al. Hyponatraemia on admission to hospital is associated with increased long-term risk of mortality in survivors of myocardial infarction. Eur J Prev Cardiol, 2015; 22, 1419-26. doi:  10.1177/2047487314557963
[12] Choi JS, Kim CS, Bae EH, et al. Prognostic impact of hyponatremia occurring at various time points during hospitalization on mortality in patients with acute myocardial infarction. Medicine (Baltimore), 2017; 96, e7023. doi:  10.1097/MD.0000000000007023
[13] Klein L, O'Connor CM, Leimberger JD, et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure:results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation, 2005; 111, 2454-60. doi:  10.1161/01.CIR.0000165065.82609.3D
[14] Gheorghiade M, Abraham WT, Albert NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure:an analysis from the OPTIMIZE-HF registry. Eur Heart J, 2007; 28, 980-8. doi:  10.1093/eurheartj/ehl542
[15] Grodin JL, Verbrugge FH, Ellis SG, et al. Importance of Abnormal Chloride Homeostasis in Stable Chronic Heart Failure. Circ Heart Fail, 2016; 9, e2453. http://cn.bing.com/academic/profile?id=7d2d69c5e36a7608ff5e524fcf09e038&encoded=0&v=paper_preview&mkt=zh-cn
[16] Testani JM, Hanberg JS, Arroyo JP, et al. Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure. Eur J Heart Fail, 2016; 18, 660-8. doi:  10.1002/ejhf.2016.18.issue-6
[17] Ferreira JP, Girerd N, Duarte K, et al. Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection Fraction:An Analysis From the High-Risk Myocardial Infarction Database Initiative. Circ Heart Fail, 2017; 10, e003500. http://cn.bing.com/academic/profile?id=e29c57fe7f8427f0ad12f88140fadca5&encoded=0&v=paper_preview&mkt=zh-cn
[18] Xu JJ, Jiang L, Xu LJ, et al. Association of CDKN2B-AS1 Polymorphisms with Premature Triple-vessel Coronary Disease and Their Sex Specificity in the Chinese Population. Biomed Environ Sci, 2018; 31, 787-96. http://d.old.wanfangdata.com.cn/Periodical/bes201811001
[19] Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol, 2011; 58, e44-122. doi:  10.1016/j.jacc.2011.08.007
[20] Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol, 2011; 58, e123-210. doi:  10.1016/j.jacc.2011.08.009
[21] Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron, 1976; 16, 31-41. doi:  10.1159/000180580
[22] Girasis C, Garg S, Raber L, et al. SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions:a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. Eur Heart J, 2011; 32, 3115-27. doi:  10.1093/eurheartj/ehr369
[23] Zhang YJ, Iqbal J, Campos CM, et al. Prognostic value of site SYNTAX score and rationale for combining anatomic and clinical factors in decision making:insights from the SYNTAX trial. J Am Coll Cardiol, 2014; 64, 423-32. doi:  10.1016/j.jacc.2014.05.022
[24] Farooq V, van Klaveren D, Steyerberg EW, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients:development and validation of SYNTAX score Ⅱ. Lancet, 2013; 381, 639-50. doi:  10.1016/S0140-6736(13)60108-7
[25] Sotomi Y, Cavalcante R, van Klaveren D, et al. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease:An External Validation of the SYNTAX Score Ⅱ Model in the 1, 480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials. JACC Cardiovasc Interv, 2016; 9, 1564-72. doi:  10.1016/j.jcin.2016.04.023
[26] Cavalcante R, Sotomi Y, Mancone M, et al. Impact of the SYNTAX scores Ⅰ and Ⅱ in patients with diabetes and multivessel coronary disease:a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials. Eur Heart J, 2017; 38, 1969-77. doi:  10.1093/eurheartj/ehx138
[27] Wannamethee SG, Shaper AG, Lennon L, et al. Mild hyponatremia, hypernatremia and incident cardiovascular disease and mortality in older men:A population-based cohort study. Nutr Metab Cardiovasc Dis, 2016; 26, 12-9. doi:  10.1016/j.numecd.2015.07.008
[28] Kumar S, Berl T. Sodium. Lancet, 1998; 352, 220-8. doi:  10.1016/S0140-6736(97)12169-9
[29] Palevsky PM, Bhagrath R, Greenberg A. Hypernatremia in hospitalized patients. Ann Intern Med, 1996; 124, 197-203. doi:  10.7326/0003-4819-124-2-199601150-00002
[30] Lilly LS, Dzau VJ, Williams GH, et al. Hyponatremia in congestive heart failure:implications for neurohumoral activation and responses to orthostasis. J Clin Endocrinol Metab, 1984; 59, 924-30. doi:  10.1210/jcem-59-5-924
[31] Hanberg JS, Rao V, Ter Maaten JM, et al. Hypochloremia and Diuretic Resistance in Heart Failure:Mechanistic Insights. Circ Heart Fail, 2016; 9, e003180. http://cn.bing.com/academic/profile?id=6b7bfa7aefa45530707f4a8d0cebe553&encoded=0&v=paper_preview&mkt=zh-cn
[32] Palmer BR, Pilbrow AP, Frampton CM, et al. Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction. Eur Heart J, 2008; 29, 2489-96.
[33] Ivanes F, Susen S, Mouquet F, et al. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. Eur Heart J, 2012; 33, 191-202. doi:  10.1093/eurheartj/ehr176
[34] Swedberg K, Eneroth P, Kjekshus J, et al. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation, 1990; 82, 1730-6. doi:  10.1161/01.CIR.82.5.1730
[35] Ter Maaten JM, Damman K, Hanberg JS, et al. Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure. Circ Heart Fail, 2016; 9, e003109. http://cn.bing.com/academic/profile?id=b6e57a3d3e8286fa7fbc4462d42b01b3&encoded=0&v=paper_preview&mkt=zh-cn
[36] Neuberg GW, Miller AB, O'Connor CM, et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J, 2002; 144, 31-8. doi:  10.1067/mhj.2002.123144
[37] Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol, 2012; 60, e44-164. doi:  10.1016/j.jacc.2012.07.013